In this episode, Akin Gump intellectual property partners Cono Carrano and David Vondle discuss IP disputes at the U.S. International Trade Commission.
Among the topics covered:
- What is Section 337 and what does it mean...more
7/16/2020
/ China ,
Complaint Procedures ,
Coronavirus/COVID-19 ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Section 337 ,
Standard Essential Patents
- On June 22, 2020, the ITC issued a notice extending its COVID-19 Action Plan.
- The ITC entered Phase One of its three-phase plan to reopen to the public.
- The ITC ordered the ITC’s Administrative Law Judges to...more
6/23/2020
/ Administrative Law Judge (ALJ) ,
Coronavirus/COVID-19 ,
Court Schedules ,
Electronic Filing ,
Infectious Diseases ,
International Trade Commission (ITC) ,
Patents ,
Re-Opening Guidelines ,
Remote Proceedings ,
Rules of Practice ,
Section 337
- On May 14, 2020, the ITC extended its COVID-19 Action Plan through July 10, 2020, thereby postponing all in-person hearings in Section 337 investigations until after July 10, 2020.
- Most recently, the ITC had postponed...more
On April 15, 2020... the United States International Trade Commission (ITC) issued a Notice stating that the ITC has extended the ongoing postponement of all in-person hearings (e.g., evidentiary hearings/trials, claim...more
- In response to the COVID-19 outbreak, the United States International Trade Commission (ITC) extended the postponement of all in-person hearings, including all evidentiary hearings/trials, until June 10, 2020.
- The...more
• The International Trade Commission (ITC) can decline to institute an investigation when a complaint fails to state a cognizable claim under Section 337 of the Tariff Act, 19 U.S.C. § 1337 (“Section 337”).
• A decision...more
5/7/2019
/ Antitrust Investigations ,
Appellate Jurisdiction ,
Competition ,
Dietary Supplements ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Final Determinations ,
Food and Drug Administration (FDA) ,
International Trade Commission (ITC) ,
Jurisdiction ,
Lanham Act ,
Patents ,
Pharmaceutical Industry ,
Section 337 ,
Writ of Mandamus